Circio Holding ASA (STU:TA50) Preferred Dividends : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Circio Holding ASA Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Circio Holding ASA's preferred dividends for the six months ended in Dec. 2024 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Circio Holding ASA Preferred Dividends Historical Data

The historical data trend for Circio Holding ASA's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circio Holding ASA Preferred Dividends Chart

Circio Holding ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Preferred Dividends

Get a 7-Day Free Trial

Circio Holding ASA Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Circio Holding ASA Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Circio Holding ASA (STU:TA50) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Circio Holding ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (STU:TA50) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

CRNA:Norway 0RIS:UK

Address

Saint Olavs plass, Pb. 6887, Oslo, NOR, 0130

Website

https://www.circio.com

Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients. The company's pipeline candidate includes circVec and Mutant KRAS.

Circio Holding ASA Headlines

No Headlines